Login to Your Account

Genentech Tallies Another Quarter Of Strong Earnings

By Randall Osborne

Wednesday, July 13, 2005
Like a broken record playing a song investors never tire of hearing, Genentech Inc. chalked up another satisfying quarter, with Avastin and Herceptin sales benefiting from a parade of positive news this spring. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription